Grants

The LKCMedicine OIE together with the National Health Innovation Centre (NHIC) has set up the LKCMed-NHIC Exploratory Translational Grant, which is a platform to facilitate early-stage innovation projects at LKCMedicine. The grant is intended as internal seed funding, with the following objectives:

• To fund the development of solutions that are commercially viable to address/resolve unmet medical needs,
• To leverage on the outcomes of this seed funding to seek further competitive funding to bring the solutions to implementation.
  

Awarded through a competitive grant call process, this grant is applicable for LKCMed full-time faculty or LKCMed/NHG joint appointments with at least 0.2 FTE with LKCMedicine.

Project proposals in the MedTech (Devices/diagnostics/digital health/SaMD) and the BioTech (Biomarkers/companion diagnostics/therapeutics) categories will be awarded in this grant. 

The LKCMed-NHIC ET annual grant call, initiated in 2023, has awarded a total of six projects under the scheme. Reach out to LKC OIE at LKCMed-OIE@ntu.edu.sg to know more about the Exploratory Translational Grant and the timeline for upcoming grant calls.

Funding for development of a healthcare innovation to a commercialisable endpoint

This funding is for development of a clinically significant and commercially viable healthcare innovation. The grant application must clearly illustrate the scientific merit, competitive advantage, and technical feasibility of the project. Additionally, it must demonstrate potential for translation to a point where the technology would be attractive to an industry partner or follow-on funder.

Learn more about Innovation to Develop.

Development of clinician innovations towards Health and Biomedical Sciences Startups

I2Start program is a streamlined funding pathway which brings together three institutions: SMART, NHIC and Enterprise Singapore, in a manner to support company formation around health and biomedical science innovations.

An I2Start application must clearly illustrate the technical feasibility of the technology, a defined go-to-market strategy, and demonstrate the potential for translation to a point where the technology would be attractive for a start-up company formation.

Learn more about Innovation to Startup.

Funding which supports commercially viable innovation for implementation, adoption

Funding to support development of a clinically significant and commercially viable innovation to accelerate commercialization and eventual implementation and adoption of the innovation to impact and benefit healthcare delivery and patient care. Supports funding of enabling technologies that improve clinical outcome, including preventive intervention, therapeutic interventions, etc.

Learn more about Innovation to Adopt

Co-development of a healthcare innovation with an industry partner

The scheme is for projects which have successfully completed I2D funding (or equivalent as deemed appropriate by NHIC) and which, in conjunction with an industry partner, require co-development for the industry partner to license the technology. Application to this fund is by NHIC invitation only.

Learn more about Innovation to Industry.

The NTUitive Gap Funding is for beyond Proof-Of-Concept development. Open to NTU researchers to facilitate the commercialisation of technologies developed in NTU, the grant will go towards supporting the developmental cost of building a fully functional prototype.

Learn more about NTUitive Gap.

The Singapore Therapeutics Development Review (STDR) is a national-level grant call for public sector research, implemented by the Agency for Science, Technology and Research (A*STAR) in partnership with strategic partners, the Experimental Drug Development Centre (EDDC), Singapore-MIT Alliance for Research and Technology (SMART) and National Health Innovation Centre (NHIC).

The STDR comprises Pre-Pilot and Pilot funding stages. The Pre-Pilot stream offers grants of up to S$100,000 to support Single target/single lead drug development projects or platform discovery projects. The Pilot stage aims to identify high-value therapeutic projects within the community and render them the right support to achieve commercial success.

Learn more about Singapore Therapeutics Development Review (STDR).

The Startup SG Tech grant fast-tracks the development of proprietary technology solutions and catalyses the growth of startups based on proprietary technology and a scalable business model. Startup SG Tech is a competitive grant that supports Proof-of-Concept (POC) and Proof-of-Value (POV) for commercialisation of innovative technologies. Companies may apply for POC or POV grants depending on the stage of development of the technology/concept.

Learn more about ESG StartSG Grant.

The Innovation 2.0 grant program is a flagship program that will enable a qualified team of scientists and researchers to launch successful ventures, with funding, training, and intense mentoring provided across three gated grant phases. The SMART Innovation Centre (SMART IC) will conduct a grant call annually and enrol up to 10 projects in the Venture Exploration Workshop. It can then issue up to 5 Venture Design Grants per year ($300K each) and up to 3 Venture Execution Grants per year ($500K each).

Learn more about Innovation 2.0. 

Temasek Foundation supports the last-mile translation, adoption and scaling of innovative and cost-effective technological solutions that improve health. Solutions that seek to deliver positive health outcomes, improved patient outcomes and experience, better affordability, reduced burden on caregivers and healthcare providers are supporting under this funding scheme.

Please contact LKCMed-OIE@ntu.edu.sg to know more or if you are interested to apply for this funding.

The Nucleic Acid Therapeutics Initiative (NATi) is a National Platform with the mission of building up Singapore as the regional hub and model of excellence for research, clinical translation and commercialisation of nucleic acid therapeutics (NAT). Specifically, NATi focuses on the following modalities: antisense oligonucleotides (ASO), small interfering RNA (siRNA) and messenger RNA (mRNA).

Learn more about NATi grant calls here https://www.a-star.edu.sg/nati/calls-for-proposals.